In this study of obstructive sleep apnoea (OSA), glucose tolerance and liver steatosis in females from an obesity unit, 45 patients (mean age 46.8 years, mean body mass index 39.4 kg/m2, all non-diabetic and alcohol abstainers) underwent nocturnal polysomnography, a 2 h oral glucose tolerance test and abdominal ultrasonography. OSA, defined as an apnoea–hypopnoea index (AHI) of ≤ 10 events/h, was present in 20 patients (44%). Impaired glucose tolerance (IGT) was found in eight patients (40%) with OSA and three patients (12%) without OSA; there was a positive linear relationship between AHI and post-load glucose levels. On multivariate logistic regression analysis, IGT was predicted by OSA independently of age, waist circumference, systolic blood pressure and current smoking. Liver steatosis was present in 37 women (82.2%), of whom six had grade III steatosis. Of the variables tested, IGT was the only predictor of grade III steatosis. In conclusion, OSA is an independent predictor of IGT which, in turn, is associated with severe liver steatosis in an obesity unit-based sample of women.
SkarforsETSelinusKILithellHO: Risk factors for developing non-insulin dependent diabetes: A 10 year follow up of men in Uppsala. BMJ1991; 303: 755–760.
2.
HarrisMIHaddenWCKnowlerWC: Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 24–74 yr. Diabetes1987; 36: 523–534.
3.
BlakeDRMeigsJBMullerDC: Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: Results from the Baltimore Longitudinal Study on Aging. Diabetes2004; 53: 2095–2100.
4.
VermeerSESandeeW, Algra A, et al for the Dutch TIA Trial Study Group: Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke. Stroke2006; 37: 1413–1417.
5.
SaydahSHLoriaCMEberhardtMS: Subclinical states of glucose intolerance and risk of death in the US. Diabetes Care2001; 24: 447–453.
6.
AndersenTChristoffersenPGluudC: The liver in consecutive patients with morbid obesity: A clinical, morphological, and biochemical study. Int J Obes1984; 8: 107–115.
PekerYHednerJNorumJ: Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: A 7-year follow-up. Am J Respir Crit Care Med2002; 166: 159–165.
14.
ZanchettiAChalmersJPArakawaK: The 1993 guidelines for the management of mild hypertension: Memorandum from a WHO/ISH meeting. Blood Press1993; 2: 86–100.
15.
AlbertiKGZimmetPZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus—provisional report of a WHO consultation. Diabet Med1998; 15: 539–553.
16.
American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care2005; 28: S37–S42.
17.
MatthewsDRHoskerJPRudenskiAS: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia1985; 28: 412–419.
18.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA2001; 285: 2486–2497.
19.
ScatarigeJCScottWWDonovanPJ: Fatty infiltration of the liver: Ultrasonographic and computed tomographic correlation. J Ultrasound Med1984; 3: 9–14.
20.
RechtschaffenAKalesA: A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages in Human Subjects. Los Angeles: Brain Information Service, UCLA, 1968.
21.
LaviePHererPHoffsteinV: Obstructive sleep apnoea syndrome as a risk factor for hypertension: Population study. BMJ2000; 320: 479–482.
22.
TiihonenMPartinenMNarvanenS: The severity of obstructive sleep apnoea is associated with insulin resistance. J Sleep Res1993; 2: 56–61.
23.
VgontzasANPapanicolaouDABixlerEO: Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab2000; 85: 1151–1158.
24.
BrooksBCistulliPABorkmanM: Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: Effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab1994; 79: 1681–1685.
PunjabiNMSorkinJDKatzelLI: Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med2002; 165: 677–682.
27.
MeslierNGagnadouxFGiraudP: Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J2003; 22: 156–160.
AssyNKaitaKMyminD: Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci2000; 45: 1929–1934.
30.
DonatiGStagniBPiscagliaF: Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: Role of insulin resistance. Gut2004; 53: 1020–1023.
31.
ClarkJM: The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol2006; 40 (suppl 1): S5–10.
32.
ChinKNakamuraTTakahashiK: Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med2003; 114: 370–376.
JosephAESaverymuttuSHal-SamS: Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol1991; 43: 26–31.
35.
MendlerMHBouilletPLe SidanerA: Dual-energy CT in the diagnosis and quantification of fatty liver: Limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol1998; 28: 785–794.
36.
GraifMYanukaMBarazM: Quantitative estimation of attenuation in ultrasound video images: Correlation with histology in diffuse liver disease. Invest Radiol2000; 35: 319–324.
37.
PiccininoFSagnelliEPasqualeG: Complications following percutaneous liver biopsy. A multicentre retrospective study on 68 276 biopsies. J Hepatol1986; 2: 165–173.
